Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Interviews
    • Sign up for alerts
  • About us
    • About BiO
    • Editors and Board
    • Editor biographies
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contact
    • Contact BiO
    • Advertising
    • Feedback
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

User menu

  • Log in

Search

  • Advanced search
Biology Open
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

supporting biologistsinspiring biology

Biology Open

Advanced search

RSS   Twitter   Facebook   YouTube

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Interviews
    • Sign up for alerts
  • About us
    • About BiO
    • Editors and Board
    • Editor biographies
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contact
    • Contact BiO
    • Advertising
    • Feedback
First Person
First person – Sebastian Markert
Biology Open 2020 9: bio057760 doi: 10.1242/bio.057760 Published 7 December 2020
  • Article
  • Figures & tables
  • Info & metrics
  • eLetters
  • PDF
Loading

ABSTRACT

First Person is a series of interviews with the first authors of a selection of papers published in Biology Open, helping early-career researchers promote themselves alongside their papers. Sebastian Markert is first author on ‘Overexpression of an ALS-associated FUS mutation in C. elegans disrupts NMJ morphology and leads to defective neuromuscular transmission’, published in BiO. Sebastian conducted the research described in this article while a PhD student in Christian Stigloher's lab at Imaging Core Facility, Biocenter, University of Wuerzburg, Germany. He is now a Postdoc in the lab of Shigeki Watanabe in Baltimore, USA, investigating how neurons communicate with each other on the molecular level.

Embedded Image

Sebastian Markert

What is your scientific background and the general focus of your lab?

I am fascinated by almost all fields of biology and luckily had a very broad education at the University of Würzburg in Germany. In the end, neurobiology won, and I joined the Stigloher lab to do my PhD. They use advanced light and electron microscopy techniques for cutting-edge neurobiology research. The main model of the lab is the worm C. elegans, that I fell in love with on first sight. It is such a great model organism for basic research.

How would you explain the main findings of your paper to non-scientific family and friends?

Muscle wasting diseases are often severe and cause premature death. Scientists are trying to figure out how these diseases work so we can develop treatments. In the one variety we studied, the nerve cells that move the muscle wither and die (and that is causing the wasting of the muscle). Unfortunately, it is very hard to study why these nerve cells die in human patients. Amazingly, though, it is possible to cause the muscle wasting symptoms in tiny worms that are much easier to study. We gave them the mutated human protein that causes the disease and they too died prematurely and could not move very well. We then used light and electron microscopy to look at the nerve cells and also measured their nerve signals with a tiny electrode. We found that the nerve cells have indeed trouble sending their signals to the muscles and they also looked different. This shows that the worm C. elegans might be a good model to study the disease in the future and gives some insights as to why and how the nerve cells are dying.

“… C. elegans might be a good model to study [ALS] in the future and gives some insights as to why and how the nerve cells are dying.”

What are the potential implications of these results for your field of research?

Our study makes a strong case for the usefulness of C. elegans as a model for the muscle wasting disease amyotrophic lateral sclerosis (ALS). Future studies with the worm model could offer some decisive breakthroughs in ALS research. We also show how advanced light and electron microscopy techniques can work together to investigate disease mechanisms.

What has surprised you the most while conducting your research?

Humans and C. elegans worms are vastly different animals. That is why I was so surprised that you can actually just put a mutant human protein that causes a disease into the worm and it develops essentially the same disease. It is amazing how conserved certain biological mechanisms are.

What changes do you think could improve the professional lives of early-career scientists?

A career in science is not easy. When I look to myself for strength, I can only try to do science that truly fascinates, inspires, and energizes me. This is what will get me through the challenging parts. I try to have the courage to not spend my time with the kind of science that others want me to do. I hope that early-career scientists get the support and encouragement to do the same.

Figure1
  • Download figure
  • Open in new tab
  • Download powerpoint

High-pressure freezing. To achieve near-native tissue preservation, live worms are cooled so fast that it is like stopping time: proteins and membranes freeze on the spot and are subsequently visualized via electron microscopy.

“When I look to myself for strength, I can only try to do science that truly fascinates, inspires, and energizes me.”

What's next for you?

I have graduated and now moved from Germany to the US to do a postdoc at Johns Hopkins University. I am still working with neurons, but this time I study the retina of zebrafish. I want to find out how photoreceptor cells translate light into nerve signals that the brain can understand. These are exciting times and I hope to learn a lot before I try to build my own lab in a few years.

Footnotes

  • Sebastian Markert's contact details: Department of Cell Biology, biophysics100, Johns Hopkins University, 725 N Wolfe St, Baltimore, MD 21205, USA.

    E-mail: scibastian.m{at}gmail.com

  • © 2020. Published by The Company of Biologists Ltd
http://creativecommons.org/licenses/by/4.0

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

Reference

  1. ↵
    1. Markert, S. M.,
    2. Skoruppa, M.,
    3. Yu, B.,
    4. Mulcahy, B.,
    5. Zhen, M.,
    6. Gao, S.,
    7. Sendtner, M. and
    8. Stigloher, C.
    (2020). Overexpression of an ALS-associated FUS mutation in C. elegans disrupts NMJ morphology and leads to defective neuromuscular transmission. Biology Open. 9, bio055129. doi:10.1242/bio.055129
    OpenUrlAbstract/FREE Full Text
View Abstract
Previous ArticleNext Article
Back to top
Previous ArticleNext Article

This Issue

RSSRSS

 Download PDF

Email

Thank you for your interest in spreading the word on Biology Open.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
First person – Sebastian Markert
(Your Name) has sent you a message from Biology Open
(Your Name) thought you would like to see the Biology Open web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
First Person
First person – Sebastian Markert
Biology Open 2020 9: bio057760 doi: 10.1242/bio.057760 Published 7 December 2020
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
First Person
First person – Sebastian Markert
Biology Open 2020 9: bio057760 doi: 10.1242/bio.057760 Published 7 December 2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Alerts

Please log in to add an alert for this article.

Sign in to email alerts with your email address

Article Navigation

  • Top
  • Article
    • ABSTRACT
    • Footnotes
    • Reference
  • Figures & tables
  • Info & metrics
  • eLetters
  • PDF

Related articles

Cited by...

More in this TOC section

  • First person – José Britto-Júnior
  • First person – Ivo de Vos
Show more FIRST PERSON

Similar articles

Other journals from The Company of Biologists

Development

Journal of Cell Science

Journal of Experimental Biology

Disease Models & Mechanisms

Advertisement

Biology Open and COVID-19

We are aware that the COVID-19 pandemic is having an unprecedented impact on researchers worldwide. The Editors of all The Company of Biologists’ journals have been considering ways in which we can alleviate concerns that members of our community may have around publishing activities during this time. Read about the actions we are taking at this time.

Please don’t hesitate to contact the Editorial Office if you have any questions or concerns.


2020 at The Company of Biologists

Despite 2020’s challenges, we achieved a lot at The Company of Biologists. In the midst of the pandemic, we have seen long-term projects and new ventures come to fruition. Read our full lowdown of 2020.


Interview- Sebastian Markert

Sebastian Markert is first author of a paper in BiO using C. elegans to model amyotrophic lateral sclerosis. In an interview, he talks about the potential implications of his work and his future plans.


Three communities to support biologists to everywhere

Online communities have never been more important. If you’re looking for somewhere to meet fellow scientists, take part in topical discussions and find virtual events in your field, take a look at each of our community sites:

  • The Node: the community site for and by developmental biologists
  • preLights: the preprint highlights service run by the biological community
  • FocalPlane: the community site for microscopists and biologists alike

Articles

  • Accepted manuscripts
  • Issue in progress
  • Latest complete issue
  • Issue archive
  • Archive by article type
  • Interviews
  • Sign up for alerts

About us

  • About BiO
  • Editors and Board
  • Editor biographies
  • Grants and funding
  • Journal Meetings
  • Workshops
  • The Company of Biologists

For Authors

  • Submit a manuscript
  • Aims and scope
  • Presubmission enquiries
  • Article types
  • Manuscript preparation
  • Cover suggestions
  • Editorial process
  • Promoting your paper
  • Open Access

Journal Info

  • Journal policies
  • Rights and permissions
  • Media policies
  • Reviewer guide
  • Sign up for alerts

Contact

  • Contact BiO
  • Advertising
  • Feedback

Twitter   YouTube   LinkedIn

© 2021   The Company of Biologists Ltd   Registered Charity 277992